PAR 15.1% 22.5¢ paradigm biopharmaceuticals limited..

Heart Failure Inflammation, page-6

  1. 4,396 Posts.
    lightbulb Created with Sketch. 6935
    Quite topical, latest news in regards to the latest variant, could be much more contagious, hearing reports it may not be necessarily harsher symptomatically. The experts will know more in a few weeks time...at any rate could certainly result in more cases of heart failure over the next few years. (Not just vaccines, but the virus [Long Covid] and mutant strains themselves leading to increased rates of heart failure/tissue damage, esp. respiratory linings/tissues)




    If we are shown to have decent efficacy in this area, a Phase 1 could become a bit of a priority, from there Phase 2 can be rushed and given official priority. Not saying there is necessarily a higher chance of all this playing out, but you just never know?


    My views
    Last edited by Mozzarc: 26/11/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.040(15.1%)
Mkt cap ! $78.80M
Open High Low Value Volume
26.5¢ 26.5¢ 22.0¢ $503.0K 2.101M

Buyers (Bids)

No. Vol. Price($)
1 10000 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 210000 2
View Market Depth
Last trade - 16.10pm 21/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.